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Abstract It is shown that in the A431 cells, EGFR is co-immunoprecipitated with a group of proteins recognized by antibodies to phospholipase 
Cy. These are 145- and 47-kDa proteins corresponding to phospholipase Cy and Nck, respectively, and an unidentified 66-kDa protein. The 
association of phosphoinositide-specific phospholipase Cy and 66-kDa protein to EGFR was observed in the A431 cells with or without the EGF 
treatment. Trypsin peptide maps of these two proteins are similar so it is assumed that the 66-kDa protein is related to phospholipase Cy. 
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1. Introduction 
Phospholipase Cyl (PLQl) is a member of a family of PLCs 
which plays a central role in cell signal transduction. PLCyl 
takes part in phosphoinositide metabolism, simultaneously 
generating two second messengers, inositol triphosphate and 
diacylglycerol, triggering Ca2’ release from intracellular 
sources and activation of protein kinase C followed by numer- 
ous cellular responses (for review see [l] and references therein). 
PLCyl binds to EGFR and PDGFR via its src homology 2 
(SH2) domain [2]. Association of PLCyl with growth factor 
receptors leads to its phosphorylation by the receptor, tyrosine 
kinase [3]. Regulation of PLCyl activity by tyrosine phospho- 
rylation has been a subject of some recent articles [3,4]. 
The existence of another member of the PLC family, PLCa 
(molecular mass 62-68 kDa) has been debated as its sequence 
was published but the enzyme was not expressed in heterolo- 
gous cells and showed no sequence homology to other PLCs, 
including absence of the catalytic domains [5]. Nevertheless the 
62-68 kDa PLCs have been isolated from a variety of cells. 
2. Materials and methods 
2.1. Cell culture and treatment 
A431 cells were cultured in Dulbecco’s minimal essential medium 
(DMEM) with 10% (v/v) fetal calf serum (Gibco) at 37°C. Cells were 
seeded in 90 mm diameter dishes (Nunc) and grown until about 80% 
confluent, then shifted in to DMEM containing 0.5% fetal calf serum 
for 15-18 h before the addition of EGF. Mouse EGF was obtained 
from Sigma. A431 cells were treated with 100 ng/ml EGF in DMEM, 
containing 0.1% BSA and 200 mM HEPES, pH 7.4, for 5 min at 37°C. 
2.2. Antibodies and immunoprecipitation 
Monoclonal anti-EGFR antibody 5A9 was developed in our labora- 
tory and has been described elsewhere [8]. Polyclonal antibody to 
c-terminal region of PLCyl (1249-1262 amino acid residues) was 
kindly provided by Dr. G. Carpenter [9]. Polyclonal antibody to SH2- 
SH3 containing the PLCyl domain and monoclonal anti-EGFR anti- 
body (Mab 108) were kindly donated by Dr. J. Schlessinger [IO]. 
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Abbreviations: EGF, epidennal growth factor; EGFR, epidermal 
growth factor receptor; PDGFR, receptor of platelet-derived growth 
factor; PLC, phosphoinositide-specific phospholipase C; Nck, a cyto- 
plasmic protein consisting of src homology units SH2 and SH3 [7,13]. 
Resting or EGF-treated cells were washed twice with ice-cold phos- 
phate buffered saline (pH 7.4) and lysed with RIPA buffer according 
to Margolis et al. [1 I]. EGFR and PLCyl were immunoprecipitated 
with anti-PLCyl or anti-EGFR antibodies with the addition of 10 ~1 
of protein A-Sepharose for 2 h at 4°C. 
2.3. Immunoblotting 
Immunocomplexes were boiled in Laemmli buffer, separated by 
SDS-PAGE and probed with anti-PLCyl antibodies. GAR-biotin and 
alkaline phosphatase detection systems (Dako) were used. 
2.4. Peptide mapping of immunoprecipitates 
Immunoprecipitates, obtained with anti-PLCyl antibodies from 
A431 cell lysates, were electrophoresed in 7% polyacrylamide gels and 
bands corresponding to PLCyl and 66-kDa protein were cut out, 
digested by modified trypsin (Sigma), subjected to 17% SDS-PAGE, 
and silver stained according to Cleaveland et al. [12]. 
3. Results and discussion 
It is known that PLCyl can associate with growth factor 
receptors. PLCyl was previously shown to be co-immunopre- 
cipitated with EGFR using anti-PLCyl antibodies. Some types 
of monoclonal antibodies to PLCyl can recognize Nck and 
other proteins containing an epitope common to PLCyl [13]. 
In our experiments, EGFR was immunoprecipitated from 
A43 1 cells lysates, isolated by SDS-PAGE, transferred to nitro- 
cellulose and subjected to Western blot with anti-PLCyl anti- 
bodies (Fig. 1). In untreated cells, a 145-kDa band correspond- 
ing to PLCyl was detected along with 66- and 60 kDa proteins. 
There are contradictory data concerning the association of 
PLCyl with EGFR in untreated A43 1 cells. Margolis et al. [ 1 l] 
found EGFR co-immunoprecipitated with anti-PLCyl anti- 
bodies in untreated A431 cells, but this association was not 
observed in NIH 3T3 cells [14]. In our experiments, co-im- 
munoprecipitation was seen with either monoclonal or polyclo- 
nal antibodies to EGFR and with two types of anti-PLCyl 
antibodies. It may be assumed that some of the EGFR mole- 
cules remain phosphorylated and bind PLCyl. Treatment of 
A431 cells with EGF failed to induce any significant changes 
in the protein set associated to EGFR and recognized by anti- 
PLCyl antibodies (Fig. 1). 
To determine whether 60- and 66-kDa proteins specifically 
bind the anti-PLCyl antibodies, PLCyl was precipitated from 
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Fig. 1. Co-immunoprecipitation of PLCyl and EGFR. A431 cells were 
lysed without (1) and with (2) EGF treatment, precipitated with anti- 
EGFR antibody and blotted with anti-PLCyl antibody. Arrows indi- 
cate the molecular weight standards from top to bottom: 170 kDa, 
97 kDa, 68 kDa, 45 kDa. 
A431 cells with or without EGF treatment and blotted using 
the same antibodies (Fig. 2). 
The HL-60 cells containing PLCy2 but not PLCyl were used 
as a control. In A431 cells, 145- and 66-kDa bands were ob- 
served. None of them were detected in HL-60 cells (not shown). 
It has been shown previously that unidentified 65kDa pro- 
tein is co-immunoprecipitated with anti-PDGFR in PAE cells 
[IS]. This protein appeared to be a major component in quies- 
cent and PDGF-treated cells [16]. A protein with the same 
molecular mass was detected by monoclonal antibodies to 
PLCyl in different experimental models. The 66-kDa protein 
was bound to B-16-5 monoclonal anti-PLCyl antibodies from 
Fig. 2. Western blots of PLCyl from A431 cell lysates. PLCyl was 
immunoprecipitated with anti-PLCyl antibody from A431 cell lysates 
without (1) or with (2) EGF treatment and blotted with the same 
antibody. Arrows indicate the molecular weight standards from top to 
bottom: 170 kDa, 97 kDa, 68 kDa, 45 kDa. 
Fig. 3. Trypsin peptide mapping of the Nck (l), 66-kDa protein (2) and 
PLCyl (3). Arrows indicate the molecular weight standards from top 
to bottom: 45 kDa, 29 kDa, 20 kDa, 14.4 kDa. 
rat brain homogenates [13]. PLCyl and an additional 65-70 
kDa protein were found in PC-12 cell nuclei using a mix of 
monoclonal antibodies to PLCyl [16]. 
These proteins could be either co-immunoprecipitated with 
PLCyl or related to it. To examine the possible relationship 
between these two proteins, digestion with trypsin and peptide 
mapping were carried out. The pattern of major polypeptides 
of PLCyl and 66-kDa protein were similar and differed from 
Nck, a 47-kDa protein also recognized by anti-PLCyl antibod- 
ies (Fig. 3). 
In our experiments amixture of protease inhibitors was used 
and all procedures were carried out on ice so that the appear- 
ance of the 66-kDa protein could hardly be a result of in vitro 
degradation of PLCyl. It seems more probable that such deg- 
radation occurs in living cells. 
It is known that in A431 cells a small amount of PLCyl is 
associated with the EGFR. We have shown that its 66-kDa 
fragment is also associated with the receptor. One may suggest 
that this association plays some role in the EGFR-PLCyl 
interaction. The binding sites of the 66-kDa protein and its 
possible role in cell signal transduction are now under study. 
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